CEMP set for nice Q1/Q2 run up

26 0 1
Cempra             ( CEMP             ) was annihilated on October 16th because in the reporting of the drug Solithromyocin's success in trials, increased pain at the injection point was noted. Essentially what happened n what should have been a positive note, ws that the hedge funds flinched, and sold off. this caused the stock to plummet from 26.78 on October 15, 2015 to 15.76 on October 22, 2015. Since then, myself and my team have purchase more shares. This drug, represents a new non antibiotic that the FDA desperately wants to see approved. Barring an unforeseen setback in the trials (which is always possible), I see this stock above 40 around April of 16.
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out